Prednisone

Generic Name
Prednisone
Brand Names
Deltasone, Rayos, Winpred
Drug Type
Small Molecule
Chemical Formula
C21H26O5
CAS Number
53-03-2
Unique Ingredient Identifier
VB0R961HZT
Background

A synthetic anti-inflammatory glucocorticoid derived from cortisone. It is biologically inert and converted to prednisolone in the liver.

Prednisone was granted FDA approval on 21 February 1955.

Indication

Prednisone is indicated as an anti-inflammatory or immunosuppressive drug for allergic, dermatologic, gastrointestinal, hematologic, ophthalmologic, nervous system, renal, respiratory, rheumatologic, infectious, endocrine, or neoplastic conditions as well as in organ transplant.

Associated Conditions
Acne Vulgaris, Acute Exacerbation of Chronic Obstructive Pulmonary Disease, Acute Gouty Arthritis, Acute Leukemia, Aggressive Lymphoma, Allergic Bronchopulmonary Aspergillosis, Allergic Conjunctivitis (AC), Allergic Rhinitis (AR), Allergic corneal marginal ulcers, Alveolitis, Extrinsic Allergic, Ankylosing Spondylitis (AS), Aspiration Pneumonitis, Asthma, Atopic Dermatitis, Autoimmune Hepatitis, Bell's Palsy, Berylliosis, Bullous dermatitis herpetiformis, Chorioretinitis, Congenital Adrenal Hyperplasia (CAH), Congenital Hypoplastic Anemia, Contact Dermatitis, Disseminated tuberculosis, Drug hypersensitivity reaction, Edema of the cerebrum, Epicondylitis, Erythroblastopenia, Giant Cell Arteritis (GCA), Hypercalcemia of Malignancy, Idiopathic Pulmonary Fibrosis (IPF), Immune Thrombocytopenia (ITP), Iridocyclitis, Iritis, Keratitis, Leukemias, Loeffler's syndrome, Lymphoma, Meningitis caused by Mycobacterium Tuberculosis, Metastatic Castration-Resistant Prostate Cancer (mCRPC), Mycosis Fungoides (MF), Ocular Inflammation, Ophthalmia, Sympathetic, Optic Neuritis, Pain caused by Herpes zoster, Pemphigus, Pericarditis, Pneumocystis Jirovecii Pneumonia, Polymyalgia Rheumatica (PMR), Polymyositis, Posterior Uveitis, Primary adrenocortical insufficiency, Psoriatic Arthritis, Pure Red Cell Aplasia, Regional Enteritis, Relapsing Polychondritis, Rheumatoid Arthritis, Rheumatoid Arthritis, Juvenile, Secondary adrenocortical insufficiency, Secondary thrombocytopenia, Serum Sickness, Severe Seborrheic Dermatitis, Sjogren's Syndrome (SS), Solid Organ Transplant Rejection, Stevens-Johnson Syndrome, Systemic Lupus Erythematosus, Takayasu Arteritis, Thyroid Eye Disease, Thyroiditis, Thyrotoxicosis, Trichinosis, Ulcerative Colitis, Uveitis, Vasculitis, Acquired immune hemolytic anemia, Acute Bursitis, Acute Crohn's Disease (CD), Acute Multiple sclerosis exacerbation, Acute rheumatic carditis, Anterior eye segment inflammation, Exfoliative erythroderma, Fulminating Tuberculosis, Idiopathic Bronchiolitis obliterans with organizing pneumonia, Idiopathic eosinophilic pneumonias, Non-suppurative Thyroiditis, Severe Psoriasis, Subacute Bursitis, Symptomatic Sarcoidosis, Synovitis of osteoarthritis, Systemic Dermatomyositis, Varicella-zoster virus acute retinal necrosis
Associated Therapies
Palliative Treatment

Combination Chemotherapy and Rituximab With Pegfilgrastim Followed by Rituximab, in Large B-Cell Non-Hodgkin's Lymphoma

First Posted Date
2005-09-19
Last Posted Date
2022-03-03
Lead Sponsor
SCRI Development Innovations, LLC
Target Recruit Count
51
Registration Number
NCT00193479
Locations
🇺🇸

Tennessee Oncology, Nashville, Tennessee, United States

🇺🇸

Florida Cancer Specialists, Fort Myers, Florida, United States

A Trial of Antenatal Treatment of Alloimmune Thrombocytopenia

First Posted Date
2005-09-19
Last Posted Date
2018-11-07
Lead Sponsor
Weill Medical College of Cornell University
Target Recruit Count
102
Registration Number
NCT00194987
Locations
🇺🇸

New York Presbyterian Hospital-Weill Cornell Medical Center, New York, New York, United States

Calcitriol, Mitoxantrone, and Prednisone in Treating Patients With Metastatic Prostate Cancer

Phase 2
Completed
Conditions
First Posted Date
2005-09-16
Last Posted Date
2017-05-03
Lead Sponsor
OHSU Knight Cancer Institute
Target Recruit Count
19
Registration Number
NCT00182741
Locations
🇺🇸

Cancer Institute at Oregon Health and Science University, Portland, Oregon, United States

Treatment for Patients With Stage III or IV Non-Hodgkin Lymphoma

First Posted Date
2005-09-16
Last Posted Date
2008-04-23
Lead Sponsor
St. Jude Children's Research Hospital
Target Recruit Count
42
Registration Number
NCT00187122
Locations
🇺🇸

St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Efficacy Studies of Corticosteroid Therapy in Community-Acquired Pneumonia

Phase 3
Completed
Conditions
First Posted Date
2005-09-15
Last Posted Date
2008-09-29
Lead Sponsor
Medical Center Alkmaar
Target Recruit Count
216
Registration Number
NCT00170196
Locations
🇳🇱

Medisch Centrum Alkmaar, Alkmaar, Noord-Holland, Netherlands

A Phase II Study of Rituximab Combined With CHOP in T-cell Angio-immunoblastic Lymphoma

First Posted Date
2005-09-15
Last Posted Date
2017-03-13
Lead Sponsor
Lymphoma Study Association
Target Recruit Count
27
Registration Number
NCT00169156
Locations
🇫🇷

Hôpital Henri Mondor, Créteil, France

🇫🇷

Service d'Hématologie - Centre Hospitalier Lyon-Sud, Pierre-Bénite cedex, France

🇫🇷

Centre Henri Becquerel, Rouen, France

and more 1 locations

Treatment of Acute Lymphoblastic Leukemia in Children

First Posted Date
2005-09-14
Last Posted Date
2013-04-25
Lead Sponsor
Dana-Farber Cancer Institute
Target Recruit Count
498
Registration Number
NCT00165178
Locations
🇺🇸

Dana-Farber Cancer Institute, Boston, Massachusetts, United States

Cyclosporine A C-2h Monitoring Versus Tacrolimus C-0h Monitoring in de Novo Liver Transplant Recipients

First Posted Date
2005-09-08
Last Posted Date
2011-04-12
Lead Sponsor
Novartis Pharmaceuticals
Target Recruit Count
171
Registration Number
NCT00149994
Locations
🇨🇭

Novartis, Basel, Switzerland

Study of Prednisone, Vinblastine, Doxorubicin, and Gemcitabine in Elderly Patients With Advanced Stages Hodgkin's Lymphoma

Phase 1
Completed
Conditions
First Posted Date
2005-09-07
Last Posted Date
2009-09-07
Lead Sponsor
University of Cologne
Target Recruit Count
60
Registration Number
NCT00147875
Locations
🇩🇪

University of Cologne, Cologne, NRW, Germany

© Copyright 2024. All Rights Reserved by MedPath